Arrivent Biopharma Inc (AVBP)

EBITDA Growth

-19.53%

TTM · Period ending:

AVBP logo

AVBP EBITDA Growth

Year-over-year change vs the same period a year earlier

Latest reported-19.53%
AVBP TTM EBITDA YoY % (-247.22% → -19.53%)
High-resolution chart · PNG

AVBP ebitda growth history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Arrivent Biopharma Inc EBITDA Growth — Trailing twelve months (TTM)
Period endingEBITDA Growth
-19.5294%
-13.952%
-106.6246%
-86.7992%
-82.9245%
-70.9056%
-40.8093%
-125.3336%
-247.2203%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.